Explore more Johnson & Johnson sites:
Share
Living Our Values
Our Commitment to Transparency and Accountability
Our Commitment to Transparency and Accountability
t Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. And for more than 130 years, we have aimed to keep people well at every age and every stage of life.
Since our company’s inception, we have been committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
As we advance our vision of a healthier world for all, we are guided by the values outlined in Our Credo. From its creation more than 75 years ago, Our Credo has declared how we will work and the stakeholders we will serve, setting a clear example of transparency and accountability. Today, we continue to live our values by setting ambitious goals with clear measures of success for all the ways in which we are changing the trajectory of health—through diversity, sustainability and community impact and by communicating openly and consistently about our work across our Pharmaceutical, MedTech and Consumer Health business sectors.
This approach enables stakeholders to make informed decisions about their interactions with Our Company. It also allows us to measure and track how we are delivering on our commitments through disclosures that give clarity into our practices and progress. We operate with Transparency and Accountability because it is the right thing to do and because these values are critical to advancing our goal of changing the trajectory of health for humanity.
Further uniting all of us at Johnson & Johnson, Our Health for Humanity 2025 Goals focus our citizenship and sustainability efforts where we believe Our Company can achieve the greatest societal impact.
How We Live Our Credo Values
With a workforce of more than 130,000 brilliant minds, we live Our Credo values every day by expanding access to healthcare; advancing public health; championing diversity, equity and inclusion; and supporting environmental health.
-
We are relentless in our focus to improve access to our innovative medicines, vaccines, devices and diagnostics in all countries—especially for underserved populations in resource-limited settings within the United States and all around the world. By continuously challenging ourselves to apply our expertise and partnering power to expand global equitable access, we enable our medicines and technologies to be more readily accessible for patients and health systems. Our actions are industry leading and have helped transform access for HIV, Tuberculosis, Ebola, Neglected Tropical Diseases and more.
We have a longstanding commitment to tackling the toughest health challenges facing underserved populations in the United States and all around the world. Working from the lab to the last mile and enabled by our dedicated Global Public Health organization, we put the world’s most underserved at the heart of everything we do—measuring our success in the number of lives improved.
We understand that today’s health challenges, big and small, can only be addressed by a diverse workforce that represents the needs of all patients and consumers. By leveraging our DEI strategy, policies, programs and culture of belonging, we strive to provide our workforce with the support and opportunities they need to help create a healthier, more equitable world for us all through transformative and inclusive healthcare solutions.Back to top
We know that human health is fundamentally linked to the health of the planet—healthy people need a healthy planet. And we are uniquely positioned to make a difference on a global scale by using our resources, expertise and convening power to deliver impact at the intersection of human and environmental health.
Innovativeness. Social Responsibility. Learn how these and other key attributes landed the company on the global corporate reputation list for the 20th year in a row and ranked the company #1 on the Pharmaceutical Industry list for the ninth consecutive year.
The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.-
Johnson & Johnson’s 2021 Health for Humanity Report details our progress in sustainability. It is also our primary source of annual disclosure on environmental, social and governance (ESG) performance and should be reviewed in conjunction with disclosures on the ESG Policies & Positions page.
-
Through our annual Janssen U.S. Transparency Report, we provide policymakers and patients with useful information about what drives the cost of healthcare, including the cost of prescription medicines. We also want to shed light on the aspects of our health system that stand in the way of patients getting needed care and, ultimately, advance the dialogue about how to deliver greater access to medicines at a more manageable cost.
-
Our Responsibility Standards for Suppliers reflect our internal values and the expectations of external stakeholders, such as customers, regulators, investors and the public. We find business relationships are more productive and effective when they are built on trust, mutual respect and common values—and we seek relationships with suppliers who share our vision. We believe that when these guiding principles are followed, both businesses and communities realize economic, social and environmental benefits.
-
At Johnson & Johnson, we believe acting ethically and responsibly is not only the right thing to do but also the right thing to do for our business. Our Johnson & Johnson Code of Business Conduct ensures that we hold ourselves and how we do business to a high standard, allowing us to fulfill our obligations to the many stakeholders we serve. Effective March 30, 2020, Johnson & Johnson amended its Code of Business Conduct to provide enhanced guidance on addressing the evolving business environment.
-
The third annual Diversity, Equity & Inclusion (DEI) Impact Review reflects on our diversity, equity and inclusion journey. At Johnson & Johnson, diverse perspectives, cultures and experiences have helped spark transformative healthcare solutions for more than 130 years. We continue to challenge ourselves on what it means to prioritize diversity and inclusion in every business decision we make. We leverage our DEI strategy, policies, programs and culture of belonging to provide our workforce the support and opportunities they need to help create a healthier, more equitable world.
-
Johnson & Johnson plays a major role in advancing human health and improving patient outcomes. Quality is a fundamental value. We believe our patients and consumers deserve consistent, reliable and high quality every time they use a product from the Johnson & Johnson family of companies. Specifically, in the healthcare industry, many of our products play a very significant role in improving people’s lives—products that patients and consumers rely on every day. Focusing on quality and compliance throughout our product lifecycle is key to ensuring continuity of supply for those who need our products to achieve or maintain good health and wellbeing. On a day-to-day basis, attention to quality is just good business, creating cost and resource efficiencies, which in turn help us become a more sustainable company over the long term.
-
Johnson & Johnson plays a leading role in advancing sustainable business. Sustainability both protects our business from risks—such as climate change risk, reputational risk and more—and furnishes us with opportunities to engage more deeply with those impacted by our business and, therefore, understand how we may better meet their expectations and needs. In this way, we are better equipped to allocate resources to deliver the health solutions the world needs most. Given our large size and geographical breadth, it is imperative that we take a proactive leadership approach to sustainability and maintain a supportive governance structure to keep us on track.
-
Our Credo provides Johnson & Johnson with a clear, compelling, and enduring reminder of our responsibility to the environment. It states we must be good citizens in the global community, and we must protect the environment and natural resources we are privileged to use. We believe that the health of people is inextricably linked to the health of the planet. We have been setting public environmental performance goals for nearly 30 years. As the world’s largest, most broadly based healthcare company, we remain committed to improving the environmental health of the places where we live, work and sell our products today—and for generations to come.
-
Johnson & Johnson understands that climate health can affect human health. In fact, we’re seeing climate change impact health in new ways by changing infectious disease patterns and increasing the risk of drought and food insecurity. We have taken sustained, long-term action to reduce our greenhouse gas emissions and we are encouraging our suppliers to do the same. We also support responsible climate and energy policy around the world.
-
Every day, we work to put people first—from proactive and transparent medical safety surveillance, to groundbreaking real-world evidence applications, pediatric clinical research advancements, early access innovation and more. Our Chief Medical Officers drive medical safety excellence and innovation across our Pharmaceuticals, Medical Devices and Consumer Health sectors. Johnson & Johnson is committed to ethical decision-making and transparency to guide every decision we make.
-
At Johnson & Johnson, we blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. This aspiration includes impacting patients, consumers and all others who use our products, as well as the health of our employees, our communities and the planet. In our policies and positions, we address a broad range of environmental, social and governance (ESG) issues that are important to Johnson & Johnson and our stakeholders.
Find the latest webcasts, presentations, news and upcoming events.Honoring Our Commitment
Addressing the complexity of today’s global health environment demands unprecedented levels of innovation and agility, which is why we at Johnson & Johnson are committed to building on the incredible momentum of the past year to help healthy families flourish in healthier societies on a healthier planet.
At Johnson & Johnson, we have an opportunity to create healthier communities in a more equitable world for the millions of lives we touch every day. … Our longstanding commitment to DEI and the values of Our Credo have prepared us to meet this moment. … Together, we can advance diversity, equity and inclusion to change the trajectory of health for all.
As the world’s largest healthcare company, we’ve been building that trust for more than a century. It is Our Credo values that have helped guide the important work that we do, defining our first responsibilities to the patients, doctors and nurses, the mothers and fathers, and everyone who uses our products and services.
In January 2020, Janssen scientists immediately mobilized to begin researching and developing a COVID-19 vaccine for use globally that earned Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) and several other health authorities in the early spring of 2021. Today, millions of doses have been administered around the world.
Johnson & Johnson understands that climate health can affect human health. In fact, we’re seeing climate change impact health in new ways by changing infectious disease patterns and increasing the risk of drought and food insecurity. We have taken sustained, long-term action to reduce our greenhouse gas (GHG) emissions, and we are encouraging our suppliers to do the same. We also support responsible climate and energy policy around the world.
Every day, we work to put people first—from proactive and transparent medical safety surveillance to groundbreaking real-world evidence applications, pediatric clinical research advancements, early access innovation and more. … Johnson & Johnson’s OCMO is constantly reviewing, monitoring and making decisions regarding the safety of our products through people-driven processes, initiatives and policies that are reinforced by a single medical safety standard, to which all our products are held.
As stated in Our Credo, everything we do must be of high quality. It is our first responsibility to people around the world who use and trust Johnson & Johnson products. Every employee of Our Company proudly accepts this responsibility every day.
Sustainability both protects our business from risks—such as climate change risk, reputational risk and more—and furnishes us with opportunities to engage more deeply with those impacted by our business and, therefore, understand how we may better meet their expectations and needs. In this way, we are better equipped to allocate resources to deliver the health solutions the world needs most.
We believe solving the challenges facing frontline health workers will improve healthcare for everyone. We are working to create stronger, more equitable community-based health systems, with frontline health workers—nurses, midwives and community health workers—central to solutions. Learn more, and become involved, by subscribing to our monthly newsletter.
We invest in purpose-driven entrepreneurs innovating at the front lines of care—in pursuit of the best ideas that push boundaries and surface new opportunities to advance community-based health. Subscribe to our newsletter and join us on the journey toward a more equitable future where health is within the reach of everyone, everywhere.Latest News From Johnson & Johnson
-
November 15, 2022Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company's longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
-
October 18, 2022Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
ON NOW
Johnson & Johnson Executive Jennifer Taubert Named to Fortune’s 2022 Most Powerful Women List
October 04, 2022The company leader has been named to the prestigious list—which honors 50 women at the top of their industries—for the seventh year in a row. -
September 19, 2022Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.
-
July 19, 2022Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
June 08, 2022Championing global health equity, advancing environmental health and empowering its employees to be their best are just some of the ways Johnson & Johnson is working to help improve the well-being of people around the world. The company's 2021 Health for Humanity Report reveals just how far it's come toward these ambitious goals.
